# Efficacy of Nano-Pso Therapy in Menopause

> **NCT06432816** · NA · RECRUITING · sponsor: **Distribuidora Biolife SA de CV** · enrollment: 90 (estimated)

## Conditions studied

- Menopause
- Vasomotor; Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** NANO-PSO
- **OTHER:** PLACEBO

## Key facts

- **NCT ID:** NCT06432816
- **Lead sponsor:** Distribuidora Biolife SA de CV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-28
- **Primary completion:** 2025-02
- **Final completion:** 2026-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06432816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06432816, "Efficacy of Nano-Pso Therapy in Menopause". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06432816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*